Novo-Nordisk AS/ DK0062498333 /
| 2024-05-17 3:08:48 PM | Chg. -0.8200 | Volume | Bid7:05:35 PM | Ask7:05:35 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 121.5800EUR | -0.67% | 552 Turnover: 67,078.4600 |
120.6400Bid Size: 125 | 121.0000Ask Size: 125 | 415.9 bill.EUR | - | - |
GlobeNewswire
01-04
Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel trea...
GlobeNewswire
2019-06-18
Hormone Replacement Therapy Market Forecasts to 2024: Anticipating a CAGR of Approx 6.5%
GlobeNewswire
2019-01-09
Global Hereditary Hematological Disorders Drug Development Pipeline Review 2018
GlobeNewswire
2018-12-20
Global Biologics Market Outlook to 2023, Expected to Grow with a CAGR of 4.69%
GlobeNewswire
2018-12-17
Chronic Respiratory Disease Drug Development Pipeline Review, 2018: Therapeutics Under Development a...
GlobeNewswire
2017-12-12
Global Safety Needles Market to be worth US$ 8,000 Mn by 2027 - Future Market Insights
GlobeNewswire
2017-03-08
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action Law...
GlobeNewswire
2017-02-08
NVO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving No...
GlobeNewswire
2017-02-03
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action ...
GlobeNewswire
2017-01-17
NVO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involvin...
